Literature DB >> 11835788

[Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].

X Li1, Y Jiang, C Ye, C Li.   

Abstract

OBJECTIVE: To determine the timing of vitrectomy for proliferative diabetic retinopathy with severe vitreous hemorrhage, retinal traction and even tractional detachment resulted from fibrovascular membranes in type II diabetes mellitus.
METHODS: According to the preoperative duration of vitreous hemorrhage and severity of diabetic retinopathy, 78 eyes of 64 cases having undergone vitrectomy were divided into 2 groups for the comparison of postoperative visual acuity.
RESULTS: After 9 months of follow-up, in the group with preoperative vitreous hemorrhage of <or= 6 months' duration 42.1% of cases had visual acuity of >or= 0.3, while in the group with preoperative vitreous hemorrhage of > 6 months' duration 5.3% of cases reached such a level (P < 0.01). After one year, in the group with preoperative vitreous hemorrhage of <or= 6 months 35.7% of cases had visual acuity of >or= 0.5, while in the group with preoperative vitreous hemorrhages of > 6 months' duration, 7.1% (P < 0.05). In the group of vitreous hemorrhage with or without local tractional retinal detachment, 35.7% had visual acuity of >or= 0.5, while in the group with large area of tractional retinal detachment, 16.7% (P < 0.05).
CONCLUSION: Earlier vitrectomy is preferable for type II diabetes mellitus with vitreous hemorrhage, and the operative treatment should not be abandoned for the patients with vitreous hemorrhage of longer duration and severe tractional retinal detachment.

Entities:  

Mesh:

Year:  1999        PMID: 11835788

Source DB:  PubMed          Journal:  Zhonghua Yan Ke Za Zhi        ISSN: 0412-4081


  1 in total

1.  Individualised treatment of proliferative diabetic retinopathy: optimal surgical timing improves long-term outcomes.

Authors:  Stefano Zenoni; Natalia Comi; Piero Fontana
Journal:  EPMA J       Date:  2010-03-10       Impact factor: 6.543

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.